By Lauren Schmitt, PhD Date February 25, 2026 Everyday, our families are taking their loved ones to clinic appointments, research visits, or under the worst
In a recent preclinical study, researchers at McGill University found that metformin (an FDA-approved treatment for type 2 diabetes) improved behavior and memory in a
By: Lauren Schmitt, PhD, Chief Science Officer, PMSF Date: December 22, 2025 How Families Can Help Protect the Path to New Treatments Clinical trials are
Why Nutrition Matters in Phelan-McDermid Syndrome By: Meagan Hutchinson, Science & Research Administrator, Phelan-McDermid Syndrome Foundation December 18, 2025 Nutrition plays a critical role in
Neuren’s Phase 3 NNZ-2591 Trial for Phelan-McDermid Syndrome is Now Active! by: Lauren Schmitt, PhD Date: December 15, 2025 The Phelan-McDermid Syndrome Foundation is sharing an
Updates on the PMS Natural History Study By: Lauren Schmitt, PhD, Chief Science Officer, Phelan-McDermid Syndrome Foundation December 11, 2025 What is the Natural History
Phelan-McDermid Syndrome Foundation Names Robbie Baker as Chief Executive Officer by: Denise Croden, President, Phelan-McDermid Syndrome Foundation We are excited to share an important milestone
Together We Are Mighty: Attending the 2025 NORD Breakthrough Summit By: Meagan Hutchinson This week, I had the privilege of attending the 2025 NORD Rare
Driving Research Breakthroughs Funding research, treatments, and cures for Phelan-McDermid Syndrome The Phelan-McDermid Syndrome Foundation is proud to launch Driving Research Breakthroughs, a new way
SPACES Webinar Series Recap: Understanding Catatonia in Autism By Meagan Hutchinson Phelan-McDermid Syndrome Foundation proudly co-sponsored the six-part “Supporting People with Autism and Catatonia through